National Centre for Pharmacoeconomics
NCPE Ireland
We believe that there is currently insufficient evidence to support the reimbursement of this product under the Community Drugs Schemes.
Cost effectiveness analysis of a universal infant hepatitis B vaccination programme in Ireland